Bernd Hirsch - Evotec SE Member of the Supervisory Board
| EVOTF Stock | USD 10.18 3.65 26.39% |
Executive
Mr. Bernd Hirsch was Independent Vice Chairman of the Supervisory Board at Evotec AG since June 9, 2015. Previously he was Member of the Supervisory Board at Evotec AG from June 2014. He is Chairman of the Audit Committee and Member of the Remuneration and Nomination Committee at the Company. He completed his degree in business administration at JuliusMaximiliansUniversitaet Wuerzburg and afterwards gained experience in various positions in the financial area. From 1998 to 2001, he was Audit Manager at the audit firm Arthur Andersen. In 2001, he started at Carl Zeiss Group as Head of Mergers Acquisitions. One year later, Mr. Hirsch was appointed Chief Financial Officer and Member of the Executive Board at Carl Zeiss Meditec AG. From December 2009 to December 2015, he was Chief Financial Officer and member of the Executive Board of Symrise AG. From April 1, 2016 onwards, Mr. Hirsch was Chief Financial Officer of Bertelsmann SE Co. KGaA. Furthermore, he acts as Director of Bertelsmann Inc. and RTL Group S.A. since 2015.
| Age | 47 |
| Tenure | 9 years |
| Phone | 49 40 560 81 0 |
| Web | https://www.evotec.com |
Evotec SE Management Efficiency
Evotec SE's management efficiency ratios could be used to measure how well Evotec SE manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kristen Williams | Pacira Pharmaceuticals | 44 | |
| David Boyer | Neurocrine Biosciences | 44 | |
| Peter Norman | Alkermes Plc | N/A | |
| David Gusky | Avadel Pharmaceuticals PLC | 39 | |
| Malcolm LloydSmith | Neurocrine Biosciences | 62 | |
| Kristen JD | Pacira Pharmaceuticals | 50 | |
| Dimitri Grigoriadis | Neurocrine Biosciences | 66 | |
| Jason Vaughn | Avadel Pharmaceuticals PLC | N/A | |
| Oliver Rosen | Deciphera Pharmaceuticals LLC | 52 | |
| Michael MD | Ironwood Pharmaceuticals | 64 | |
| Bart Dunn | Collegium Pharmaceutical | N/A | |
| Stephen Schiavo | Alkermes Plc | N/A | |
| Lisa Price | Deciphera Pharmaceuticals LLC | N/A | |
| Mary Fritz | Prestige Brand Holdings | N/A | |
| Matthew MD | Deciphera Pharmaceuticals LLC | 68 | |
| Susan Mesco | Pacira Pharmaceuticals | N/A | |
| Dashyant Dhanak | Deciphera Pharmaceuticals LLC | 63 | |
| Mike Nanfito | Ironwood Pharmaceuticals | N/A | |
| Max Reinhardt | Pacira Pharmaceuticals | 53 | |
| Daniel Martin | Deciphera Pharmaceuticals LLC | 49 | |
| Jerad Seurer | Avadel Pharmaceuticals PLC | N/A | |
Management Performance
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0012 |
Evotec SE Leadership Team
Elected by the shareholders, the Evotec SE's board of directors comprises two types of representatives: Evotec SE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Evotec. The board's role is to monitor Evotec SE's management team and ensure that shareholders' interests are well served. Evotec SE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Evotec SE's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthias Evers, Chief Board | ||
| Werner Lanthaler, President of the Management Board, CEO | ||
| Claus Braestrup, Member of the Supervisory Board | ||
| Michael Shalmi, Member of the Supervisory Board | ||
| Monika Conradt, Global HR | ||
| Christian Dargel, EVP Compliance | ||
| Mario Polywka, COO and Member of Management Board | ||
| Anja Bosler, Principal Accounting | ||
| Mary Tanner, Member of the Supervisory Board | ||
| Volker Braun, VP ESG | ||
| Roland Oetker, Deputy Chairman of the Supervisory Board | ||
| Andreas Pinkwart, Member of the Supervisory Board | ||
| Paul Herrling, Member of the Supervisory Board | ||
| Colin Bond, CFO and Member of Management Board | ||
| Cord Dohrmann, Chief Scientific Officer and Member of Management Board | ||
| Iris LoewFriedrich, Member of the Supervisory Board | ||
| Bernd Hirsch, Member of the Supervisory Board | ||
| Enno Spillner, CFO, Member of the Management Board | ||
| Elaine Sullivan, Member of the Supervisory Board | ||
| Gabriele Hansen, Vice President Corporate Communications & Investor Relations | ||
| MBA MBA, Chairman CEO | ||
| Craig Johnstone, COO, Member of the Management Board | ||
| Wolfgang Plischke, Chairman of the Supervisory Board |
Evotec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Evotec SE a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0012 | |||
| Profit Margin | (0.26) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 2.68 B | |||
| Shares Outstanding | 176.95 M | |||
| Shares Owned By Insiders | 9.86 % | |||
| Shares Owned By Institutions | 66.12 % | |||
| Price To Earning | 347.66 X | |||
| Price To Book | 2.28 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Evotec SE in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Evotec SE's short interest history, or implied volatility extrapolated from Evotec SE options trading.
Pair Trading with Evotec SE
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evotec SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will appreciate offsetting losses from the drop in the long position's value.Moving against Evotec Pink Sheet
| 0.84 | TEVA | Teva Pharmaceutical | PairCorr |
| 0.42 | LRDG | Lord Global Corp | PairCorr |
The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE to buy it.
The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evotec SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evotec SE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evotec SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Evotec Pink Sheet analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |